Copyright
©The Author(s) 2016.
World J Cardiol. Feb 26, 2016; 8(2): 163-179
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.163
Published online Feb 26, 2016. doi: 10.4330/wjc.v8.i2.163
Carrier | Size range (nm) | Preparation method | Advantages for drug delivery | Disadvantages for drug delivery | Ref. |
Liposomes and polymerosomes | 10-2000 | Self-assembly in aqueous solutions | High drug-carrying capacity Good for hydrophobic and hydrophilic drugs Surface functionalization possible Simple preparation | Batch-to-batch variability Difficulties in sterilization | [123,135,138,141,143,150,161,178] |
Microbubbles | 10-1000 | Various depending on type | Surface functionalization possible | Not good for hydrophobic drugs Low drug-carrying capacity | [145-148,166,168,179] |
Polymeric micelles | 10-100 | Direct organization or controlled aggregation in solvent | Long blood circulation time Surface functionalization possible Simple preparation | Not good for hydrophobic drugs Low drug-carrying capacity | [123,136,137,155,158] |
Nanoparticles and nanospheres | 10-100 | Nanoparticles: Polymerization of monomers by emulsion Nanospheres: Interfacial polymerization and phase inversion with polymeric emulsions | Shape, size and mechanical properties tunable Possibility for controlled release | Toxicity of residual chemicals from preparation process Limited cellular uptake and degradation | [123,126,128,139,150,151,155,180] |
Dendrimeres | 1-10 | Convergent or divergent synthesis | High functionalized surface | Difficult preparation process Toxicity | [123,154,156] |
- Citation: Kamps JA, Krenning G. Micromanaging cardiac regeneration: Targeted delivery of microRNAs for cardiac repair and regeneration. World J Cardiol 2016; 8(2): 163-179
- URL: https://www.wjgnet.com/1949-8462/full/v8/i2/163.htm
- DOI: https://dx.doi.org/10.4330/wjc.v8.i2.163